Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rylomine in Acute Post-Operative Pain
NCT00390039Phase 3Completed
- Sponsor
- Javelin Pharmaceuticals
- Start
- May 2006
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of morphine in postoperative pain, sponsored by Javelin Pharmaceuticals. Primary endpoint: Sum of the Pain Intensity Differences. Started May 2006; status: completed.
02
Drugs
morphine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00390039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00390039.